ONLINE DATABASE SEARCH - OI-LS-305-MEMO
1. 44074 OI-LS-305; SCIFINDER-OI-9/14/2004
Natural and experimental infection of immunocompromised rhesus macaques (Macaca mulatta) with the microsporidian Enterocytozoon bieneusi genotype D
Green, Linda C, Didier, Peter J, Bowers, Lisa C, and Didier, Elizabeth S
Microbes and Infection 2004. 6(11): 996-1002
2. 44075 OI-LS-305; SCIFINDER-OI-9/14/2004
Synthesis and antimicrobial evaluation of 3-hydrazino-quinoxaline derivatives and their cyclic analogues
El-Bendary, ER, Goda, FE, Maarouf, AR, and Badria, FA
Scientia Pharmaceutica 2004. 72(2): 175-185
3. 44076 OI-LS-305; SCIFINDER-OI-9/14/2004
The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis
Melkusova, S, Bujdakova, H, Vollekova, A, Myoken, Y, and Mikami, Y
Pharmazie 2004. 59(7): 573-574
4. 44077 OI-LS-305; SCIFINDER-OI-9/14/2004
Discovery of fungicide micafungin
Hashimoto, Seiji
Gendai Kagaku 2004. 399: 56-61
5. 44078 OI-LS-305; SCIFINDER-OI-9/14/2004
In vitro antifungal activity of membrane-active peptides against dermatophytes and yeasts using broth microdilution method
Choi, Suk-Jin, Sung, Jung-Hyun, Kim, Jeong Aee, Lee, Dong-Youn, Lee, Joo-Heung, Lee, Eil-Soo, and Yang, Jun-Mo
Journal of Dermatological Science 2004. 35(1): 64-67
6. 44079 OI-LS-305; SCIFINDER-OI-9/14/2004
Chemical Composition and Antimicrobial Activity of the Essential Oils from the Gum of Turkish Pistachio (Pistacia vera L.)
Alma, Mehmet Hakki, Nitz, Siegfried, Kollmannsberger, Hubert, Digrak, Metin, Efe, Fatih Tuncay, and Yilmaz, Necmettin
Journal of Agricultural and Food Chemistry 2004. 52(12): 3911-3914
7. 44080 OI-LS-305; PUBMED-OI-9/20/2004
Inhibition of the growth of Toxoplasma gondii in immature human dendritic cells is dependent on the expression of TNF-alpha receptor 2
Giese, A, Stuhlsatz, S, Daubener, W, and MacKenzie, CR
J Immunol 2004. 173(5): 3366-74
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15322200&dopt=abstract
8. 44081 OI-LS-305; WOS-OI-9/12/2004
Synthesis of BILN 2061, an HCVNS3 protease inhibitor with proven antiviral effect in humans
Faucher, AM, Bailey, MD, Beaulieu, PL, Brochu, C, Duceppe, JS, Ferland, JM, Ghiro, E, Gorys, V, Halmos, T, Kawai, SH, Poirier, M, Simoneau, B, Tsantrizos, YS, and Llinas-Brunet, M
ORGANIC LETTERS 2004. 6(17): 2901-2904, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223296800017
9. 44082 OI-LS-305; SCIFINDER-OI-9/14/2004
Coronamycins, peptide antibiotics produced by a verticillate Streptomyces sp. (MSU-2110) endophytic on Monstera sp
Ezra, David, Castillo, Uvidelio F, Strobel, Gary A, Hess, Wilford M, Porter, Heidi, Jensen, James B, Condron, Margaret AM, Teplow, David B, Sears, Joseph, Maranta, Michelle, Hunter, Michelle, Weber, Barbara, and Yaver, Debbie
Microbiology (Reading, United Kingdom) 2004. 150(4): 785-793
10. 44083 OI-LS-305; SCIFINDER-OI-9/14/2004
Indole mannich bases and their antimycobacterial effect
Malinka, Wieslaw and Swiatek, Piotr
Acta Poloniae Pharmaceutica 2004. 61(2): 107-111
11. 44084 OI-LS-305; WOS-OI-9/12/2004
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines
Herrera, L, Valverde, A, Saiz, P, Saez-Nieto, JA, Portero, JL, and Jimenez, MS
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2004. 23(6): 572-576, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223309000005
12. 44085 OI-LS-305; WOS-OI-9/12/2004
In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria
Seidel, V and Taylor, PW
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2004. 23(6): 613-619, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223309000011
13. 44086 OI-LS-305; WOS-OI-9/12/2004
New antivirals and antiviral resistance
Prober, CG
HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN 2004. 549: 9-12, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000222937600003
14. 44087 OI-LS-305; WOS-OI-9/12/2004
Outcome study on hepatitis C therapy with mistletoe (Viscum album L.; Abnobaviscum) and solanum lycopersicum
Matthes, H, Schad, F, Matthes, B, Biesenthal-Matthes, S, and Schenk, G
GASTROENTEROLOGY 2004. 126(4): A665-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203335
15. 44088 OI-LS-305; WOS-OI-9/12/2004
Hepatitis C combination therapy with viramidine and peginterferon alfa-2a reduces potential for ribavirin-related hemolytic anemia
Gish, R, Nelson, D, Arora, S, Braeckman, R, and Yu, G
GASTROENTEROLOGY 2004. 126(4): A681-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203410
16. 44089 OI-LS-305; WOS-OI-9/12/2004
A phase I/II dose escalation trial assessing tolerance, pharmacokinetics, and antiviral activity of NM283, a novel antiviral treatment for hepatitis C
Godofsky, E, Afdhal, N, Rustgi, V, Shick, L, Duncan, L, Zhou, XJ, Chao, G, Fang, C, Fielman, B, Myers, M, and Brown, N
GASTROENTEROLOGY 2004. 126(4): A681-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203411
17. 44090 OI-LS-305; SCIFINDER-OI-9/14/2004
Antiviral oligonucleotides targeting HSV and CMV
Vaillant, Andrew and Juteau, Jean-Marc
PATENT: US 20040162254 ISSUE DATE: 20040819
APPLICATION: 2003-5737 PP: 84 pp., Cont.-in-part of WO 2004 24,919.
ASSIGNEE: (Replicor, Inc. Can.
18. 44091 OI-LS-305; WOS-OI-9/12/2004
Statistical analysis of combined substitutions in NS5A 2209-2248 of hepatitis C virus 1b infection and standard or pegylated interferon plus ribavirin therapy response
Moriguchi, H and Sato, C
GASTROENTEROLOGY 2004. 126(4): A719-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203598
19. 44092 OI-LS-305; WOS-OI-9/12/2004
Mutations of hepatitis C virus NS5B region and the response to interferon plus ribavirin combination treatment
Hamano, K, Sakamoto, N, Enomoto, N, Izumi, N, Asahina, Y, Kurosaki, M, Ueda, E, Tanabe, Y, Maekawa, S, and Watanabe, M
GASTROENTEROLOGY 2004. 126(4): A721-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203606
20. 44093 OI-LS-305; WOS-OI-9/12/2004
Efficacy of interferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in veterans with psychiatric and substance abuse disorders
Sahu, M and Bini, EJ
GASTROENTEROLOGY 2004. 126(4): A723-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203615
21. 44094 OI-LS-305; WOS-OI-9/12/2004
The effectiveness of pegylated-interferon and ribavirin combination therapy for chronic hepatitis C in an urban clinic setting compared to pivotal clinical trials
Johnson, TC, Vaseer, S, Iqbal, S, Clain, DJ, Bodenheimer, HC, and Min, AD
GASTROENTEROLOGY 2004. 126(4): A724-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203619
22. 44095 OI-LS-305; WOS-OI-9/12/2004
Antiviral properties of pegylated versus non-pegylated interferon alpha-2b against hepatitis C in cell culture
Joshi, V, Awad, K, Fermin, C, and Dash, S
GASTROENTEROLOGY 2004. 126(4): A760-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203799
23. 44096 OI-LS-305; WOS-OI-9/12/2004
Specific inhibition of hepatitis C virus replication by cyclosporin A
Sakamoto, N, Nakagawa, M, Tanabe, Y, Kanazawa, N, Maekawa, S, Koyama, T, Takeda, Y, Enomoto, N, and Watanabe, M
GASTROENTEROLOGY 2004. 126(4): A764-1
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000220890203817
24. 44097 OI-LS-305; WOS-OI-9/12/2004
Unmasking of tuberculosis following antiviral therapy for hepatitis C
Nahon, P, Brugiere, O, Marcellin, P, and Valla, D
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 2004. 28(6-7): 609-610, 2
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223191800014
25. 44098 OI-LS-305; SCIFINDER-OI-9/14/2004
Anti-infectives compounds and use for treating hepatitis C virus infection associated diseases
Chai, Deping, Duffy, Kevin J, Fitch, Duke M, Shaw, Antony N, Tedesco, Rosanna, Wiggall, Kenneth J, and Zimmerman, Michael N
PATENT: WO 2004052312 ISSUE DATE: 20040624
APPLICATION: 2003 PP: 54 pp.
ASSIGNEE: (Smithkline Beecham Corporation, USA
26. 44099 OI-LS-305; WOS-OI-9/12/2004
Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: Function of the last 21 amino acids of the C terminus in template binding and RNA synthesis
Vo, NV, Tuler, JR, and Lai, MMC
BIOCHEMISTRY 2004. 43(32): 10579-10591, 13
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223278700029
27. 44100 OI-LS-305; WOS-OI-9/12/2004
Phenyl substitution of furamidine markedly potentiates its anti-parasitic activity against Trypanosoma cruzi and Leishmania amazonensis
de Souza, EM, Lansiaux, A, Bailly, C, Wilson, WD, Hu, Q, Boykin, DW, Batista, MM, Araujo-Jorge, TC, and Soeiro, MNC
BIOCHEMICAL PHARMACOLOGY 2004. 68(4): 593-600, 8
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223207800001
28. 44101 OI-LS-305; WOS-OI-9/19/2004
Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli
Huang, LY, Sineva, EV, Hargitta, MRS, Sharma, SD, Suthar, M, Raney, KD, and Cameron, CE
PROTEIN EXPRESSION AND PURIFICATION 2004. 37(1): 144-153, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223413100019
29. 44102 OI-LS-305; WOS-OI-9/19/2004
A unified approach to polyene macrolides: Synthesis of candidin and nystatin polyols
Kadota, I, Hu, YQ, Packard, GK, and Rychnovsky, SD
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2004. 101(33): 11992-11995, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223410100016
30. 44103 OI-LS-305; WOS-OI-9/19/2004
Specific residues in the connector loop of the human cytomegalovirus DNA polymerase accessory protein UL44 are crucial for interaction with the UL54 catalytic subunit
Loregian, A, Appleton, BA, Hogle, JM, and Coen, DM
JOURNAL OF VIROLOGY 2004. 78(17): 9084-9092, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223386600013
31. 44104 OI-LS-305; WOS-OI-9/19/2004
The Mycobacterium tuberculosis sigJ gene controls sensitivity of the bacterium to hydrogen peroxide
Hu, YM, Kendall, S, Stoker, NG, and Coates, ARM
FEMS MICROBIOLOGY LETTERS 2004. 237(2): 415-423, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223385700032
32. 44105 OI-LS-305; WOS-OI-9/19/2004
Dynamics of Toxoplasma gondii differentiation
Dzierszinski, F, Nishi, M, Ouko, L, and Roos, DS
EUKARYOTIC CELL 2004. 3(4): 992-1003, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223418000018
33. 44106 OI-LS-305; WOS-OI-9/19/2004
Novel bisbenzamidines as potential drug candidates for the treatment of Pneumocystis carinii pneumonia
Eynde, JJV, Mayence, A, Huang, TL, Collins, MS, Rebholz, S, Walzer, PD, and Cushion, MT
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2004. 14(17): 4545-4548, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223382000035
34. 44107 OI-LS-305; WOS-OI-9/19/2004
New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase
Ivanov, AV, Kozlov, MV, Kuzyakin, AO, Kostyuk, DO, Tunitskaya, VL, and Kochetkov, SN
BIOCHEMISTRY-MOSCOW 2004. 69(7): 782-788, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223441800011
35. 44108 OI-LS-305; WOS-OI-9/19/2004
Synthesis and antiviral activities of novel 2 ',4 '- or 3 ',4 '-doubly branched carbocyclic nucleosides as potential antiviral agents
Oh, CH and Hong, JH
ARCHIV DER PHARMAZIE 2004. 337(8): 457-463, 7
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000223437900006